Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Golimumab Injection

NHS England

This public procurement record has 4 releases in its history.

Award

17 Oct 2025 at 17:40

UK7 - Contract Details Notice
Award

01 Sep 2025 at 10:26

UK6 - Contract Award Notice
Tender

14 Jul 2025 at 15:39

UK4 - Tender Notice
Planning

04 Jun 2025 at 14:23

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The NHS England, operating from Wellington House in London, has completed the tendering process for the NHS National Framework for Golimumab Injection. Commencing on 1st November 2025, this contract runs until 31st October 2026, with potential extensions up to an additional 48 months. The procurement falls under the "goods" category within the pharmaceutical products industry, with delivery anticipated across several UK regions including UKC, UKD, UKF, UKG, UKH, UKJ, and UKK. An open procedure was employed for this contract award, ensuring transparency and competitiveness. The total estimated gross value of the framework is £72 million, and the contract was officially signed on 23rd September 2025.

This tender creates significant opportunities for large-scale pharmaceutical companies with the capacity to deliver high-value goods across multiple regions. Three primary suppliers, Janssen Cilag Ltd, Mercury Pharmaceuticals Ltd, and Orifarm UK Ltd, have been awarded the contracts, demonstrating the open and competitive nature of the procurement process. Businesses equipped to offer pharmaceutical products, especially those interested in supplying within a framework agreement with potential competitive re-openings, will find such tenders beneficial for strategic market entry or expansion. SMEs have also been recognised under the suitability criteria, ensuring diverse business engagement in future procurement processes.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Golimumab Injection

Notice Description

NHS National Framework for Golimumab Injection commencing 1st November 2025 Offer reference number: CM/TNS/25/5724 Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Planning Information

NHS England is seeking to engage with suppliers that are planning to launch golimumab injection. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-052c77
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/066506-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£107,912,000 £100M-£1B
Lots Value
£107,912,000 £100M-£1B
Awards Value
£60,000,000 £10M-£100M
Contracts Value
£60,000,000 £10M-£100M

Notice Dates

Publication Date
17 Oct 202510 months ago
Submission Deadline
12 Aug 2025Expired
Future Notice Date
27 Jun 2025Expired
Award Date
26 Aug 20251 years ago
Contract Period
1 Nov 2025 - 31 Oct 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active, Pending
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
3
Supplier Names

Janssen Cilag Ltd

MERCURY PHARMACEUTICALS LIMITED

ORIFARM UK LTD

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...